RIVASTIGMINE TARTRATE (Nivagen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the RIVASTIGMINE TARTRATE drug offered from Nivagen Pharmaceuticals, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Nivagen Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | RIVASTIGMINE TARTRATE |
| SUBSTANCE NAME: | RIVASTIGMINE TARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-04 |
| END MARKETING DATE: | 0000-00-00 |
RIVASTIGMINE TARTRATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | RIVASTIGMINE TARTRATE from Nivagen Pharmaceuticals, Inc. |
| LABELER NAME: | Nivagen Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.5(mg/1) |
| START MARKETING DATE: | 2017-09-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 75834-133_1fcff583-3008-4d25-8fb4-c09454797304 |
| PRODUCT NDC: | 75834-133 |
| APPLICATION NUMBER: | ANDA203844 |
Other RIVASTIGMINE TARTRATE Pharmaceutical Manufacturers / Labelers:
